逼真肝脏组织替代物能否准确量化低kV成像对肝实质与病灶衰减及对比度的影响
本研究评估液体肝脏组织替代物(LTSL)能否模拟增强肝实质与病灶,并量化降低管电压对不同病灶对比度、增强时相和体模大小的影响。LTSL-碘溶液较水-碘溶液更准确模拟不同管电压下肝实质CT衰减;降低管电压时衰减、病灶-实质对比度(CLP)和对比噪声比(CNRLP)均升高(p < 0.001),该趋势与病灶对比度、时相和大小无关,但CLP和CNRLP的绝对改善随140 kV下CLP幅度增大而减小。
要点
- LTSL-碘溶液较水-碘溶液更准确模拟不同管电压下增强肝实质的CT衰减。
- 降低管电压时衰减、CLP和CNRLP均升高(p < 0.001),且不依赖病灶对比度、时相和大小。
- CLP和CNRLP的绝对改善与140 kV下CLP幅度呈负相关,低对比度病灶绝对改善减小。
核心结论
- LTSL能准确模拟增强肝实质和病灶的能量依赖性CT衰减特征;降低管电压对CLP和CNRLP的相对改善不依赖病灶对比度、时相和大小,但低对比度病灶的绝对改善减小。
研究设计与样本
- 液体肝脏组织替代物(LTSL)体模研究;首先测量LTSL-和水-碘溶液CT衰减随碘浓度和管电压的变化,确定模拟120 kV肝实质的碘浓度;随后用LTSL-碘模拟晚动脉期(LA:120 kV下+92 HU)和门静脉期(PV:120 kV下+112 HU)肝实质,采用两种大小的体模,创建14种高/低衰减病灶设置(病灶-实质对比度CLP = -50至+50 HU),每种CLP、时相和大小组合在恒定辐射剂量下于80、100、120和140 kV成像。
关键影像表现/征象
- LTSL-碘溶液较水-碘溶液更准确模拟不同管电压下肝实质的CT衰减。
- 降低管电压时衰减、CLP和CNRLP均升高(p < 0.001),该趋势与病灶对比度、时相和大小无关。
- CLP和CNRLP的绝对改善与140 kV下CLP幅度呈负相关。
诊断标准与关键数值
- 晚动脉期肝实质模拟目标为120 kV下+92 HU,门静脉期肝实质模拟目标为120 kV下+112 HU。
- 病灶设置覆盖病灶-实质对比度CLP = -50至+50 HU,共14种高/低衰减病灶设置。
- 在80、100、120和140 kV下测量CT衰减、CLP和CNRLP,并与理论模型比较。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To assess if a liquid tissue surrogate for the liver (LTSL) can emulate contrast-enhanced liver parenchyma and lesions and quantify the impact of reduced-kV imaging as a function of lesion contrast, phase of enhancement, and phantom size.
MATERIALS AND METHODS: First, CT attenuation of LTSL- and water-iodine solutions were measured as a function of iodine concentration and tube potential. For each solution, the iodine concentration was determined to emulate liver parenchyma at 120 kV. CT attenuation for both solutions was predicted for different tube potentials and compared to published patient data. Second, liver parenchyma in late arterial phase (LA: +92 HU at 120 kV) and portal venous phase (PV: +112 HU at 120 kV) was emulated using LTSL-iodine and a two-size phantom. Fourteen setups of hyper- and hypoattenuating lesions (lesion-to-parenchyma contrast (CLP) = -50 to +50HU) were created. Each combination of CLP, phase, and size was imaged at 80, 100, 120, and 140 kV at constant radiation dose. CT attenuation, CLP, and lesion-to-parenchyma contrast-to-noise ratio (CNRLP) were assessed and compared to a theoretical model.
RESULTS: LTSL-iodine more accurately emulated the CT attenuation of liver parenchyma across different tube potentials compared to water-iodine solutions. The theoretical model was confirmed by the empirical measurements using LTSL-iodine solutions: attenuation, CLP, and CNRLP increased when the tube potential decreased (p < 0.001). This trend was independent of lesion contrast, phase, and size. The absolute improvement in CLP and CNRLP, however, was inversely related to the magnitude of CLP at 140kV.
CONCLUSION: LTSL accurately emulated the energy-dependent CT attenuation characteristics of contrast-enhanced liver parenchyma and lesions. The relative improvement in CLP and CNRLP by applying reduced-kV imaging was independent of lesion contrast, phase, and size while the absolute improvement decreased for low-contrast lesions.
引用
- Euler A, Solomon J, FitzGerald PF, et al. Can Realistic Liver Tissue Surrogates Accurately Quantify the Impact of Reduced-kV Imaging on Attenuation and Contrast of Parenchyma and Lesions? Acad Radiol. 2018. PMID: 30269958. doi:10.1016/j.acra.2018.08.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。